This page features the latest news about the Cassava Sciences stock. Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Cassava Sciences, Inc. before investing. In this article, we go over a few key ...

No wonder that the announcement a fortnight ago by the authority of a renewed thrust to get communities to stop dumping garbage in gullies, beginning with Cassava Piece in St Andrew, failed to ...

Cassava Sciences will discontinue developing simufilam for mild to moderate Alzheimer’s disease by the end of the second quarter of this year after the experimental treatment failed to meet key Phase ...

This global staple, scientists believe, is also poised to help with hunger relief and could help stop soil erosion, according to research published in Conservation Science and Practice. “Evidence ...

KIGALI, Rwanda – Africa’s AI-driven economy must be built on a robust infrastructure that attracts capital and fuels sustainable growth, according to Hardy Pemhiwa, President and Group CEO of ...